Have a personal or library account? Click to login
Analysis of the mitochondrial 4977 bp deletion in patients with hepatocellular carcinoma Cover

Analysis of the mitochondrial 4977 bp deletion in patients with hepatocellular carcinoma

By: ZS Guo,  CL Jin,  ZJ Yao,  YM Wang and  BT Xu  
Open Access
|Jun 2017

Figures & Tables

Figure 1

Identification of the mtDNA 4977 bp deletion. M: DL2000 Marker; lane 1: control subjects without the 4977 bp deletion; lanes 2 and 3: patients with the mtDNA 4977 bp deletion.
Identification of the mtDNA 4977 bp deletion. M: DL2000 Marker; lane 1: control subjects without the 4977 bp deletion; lanes 2 and 3: patients with the mtDNA 4977 bp deletion.

Figure 2

Comparison of mtDNA content between HCC patients with the mtDNA 4977 bp deletion and control subjects.
Comparison of mtDNA content between HCC patients with the mtDNA 4977 bp deletion and control subjects.

Figure 3

Reactive oxygen species concentrations in HCC patients carrying the mtDNA 4977 bp deletion and control subjects.
Reactive oxygen species concentrations in HCC patients carrying the mtDNA 4977 bp deletion and control subjects.

Characterization of patients with hepatocellular carcinoma_

ParametersNumber of HCC PatientsmtDNA 4977 bp Deletion Frequency n (%)
Cases10410 (9.52)

Males656 (5.71)
Females404 (3.81)

Age ≥ 55757 (6.67)
Age <55303 (2.85)

History of alcohol consumption:
     yes8510 (9.52)
     no200 (0.00)

Metastasis:
     positive354 (3.81)
     negative706 (5.71)
Language: English
Page range: 81 - 86
Published on: Jun 30, 2017
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2017 ZS Guo, CL Jin, ZJ Yao, YM Wang, BT Xu, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.